NewSpring Capital Backs Pharma Co
NewSpring Capital has backed Putney, a specialty pharmaceutical company focused on providing high quality, cost-effective generic medicines for pets. The financing round will provide Putney with the capital it needs to hire additional management talent, ramp up its product acquisition and licensing program, and transform Putney into a stronger R&D and commercial organization.
5 October 2011•2 mins read
